V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290005609 | 290004063 | 1.66 | 70 | Palliative (P) | 2016-05-22 | 2016-06-04 | CAPECITABINE + CARBOPLATIN | N | N | 290024361 | CARBOPLATIN + ETOPOSIDE |
| 290005610 | 290004064 | 1.68 | 86.3 | Adjuvant (A) | 2017-09-26 | 2017-10-30 | CARBOPLATIN | 02 | Y | 290024363 | ECX |
| 290005611 | 290004065 | null | 89 | Curative (C) | 2015-06-26 | 2015-08-03 | Capecitabine | 02 | Y | 290024423 | EC + PACLITAXEL |
| 290005612 | 290004066 | 1.61 | 78.9 | Adjuvant (A) | 2015-10-20 | 2015-11-03 | Pazopanib | 02 | null | 290024495 | Y-90 |
| 290005613 | 290004066 | 1.6 | 40.9 | Palliative (P) | 2016-08-23 | 2016-08-31 | OCTREOTIDE | N | N | 290024495 | LANREOTIDE |
| 290005614 | 290007824 | 1.62 | 95.5 | Neo-adjuvant (N) | 2014-05-15 | 2014-06-05 | Cisplatin +Fluorouracil (3 wk) | N | N | 290024599 | OCTREOTIDE |
| 290005615 | 290007824 | 1.68 | 63.5 | Disease modification (D) | 2016-05-20 | 2016-05-20 | Trastuzumab 21 day maintenance | 2 | N | 290024599 | CISPLATIN + FLUOROURACIL |
| 290005616 | 290007824 | 1.77 | 92 | Curative (C) | 2016-09-12 | 2016-09-17 | OCTREOTIDE | 02 | Y | 290024599 | CISPLATIN + FLUOROURACIL |
| 290005617 | 290004067 | 0 | 55.4 | Not known (9) | 2017-04-06 | 2017-04-15 | PLATO Trials | N | N | 290024729 | FLUOROURACIL |
| 290005618 | 290004068 | 0 | null | Adjuvant (A) | 2015-09-15 | 2015-09-29 | Capecitabine | N | N | 290024760 | EOX |
| 290005619 | 290004069 | 1.68 | 69 | Curative (C) | 2015-07-23 | 2015-07-23 | CAPECITABINE + RT | N | N | 290024779 | PACLITAXEL |
| 290005620 | 290006719 | 1.66 | null | null | 2015-01-20 | 2015-01-27 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290024850 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290005621 | 290004070 | null | 64 | Palliative (P) | 2017-01-29 | 2017-02-18 | TEMOZOLOMIDE | N | N | 290024972 | CARBO + FLUOROURACIL |
| 290005622 | 290004071 | 1.6 | 78 | Palliative (P) | 2016-10-09 | 2016-10-19 | PEMBROLIZUMAB | N | N | 290024973 | CARBOPLATIN + ETOPOSIDE |
| 290005623 | 290004072 | null | 68.2 | Curative (C) | 2014-09-20 | 2014-09-20 | CHOP R - 21 days | 2 | N | 290024976 | CISPLATIN + ETOPOSIDE |
| 290005624 | 290004073 | 1.79 | null | Palliative (P) | 2014-10-11 | 2014-10-17 | Cisplatin +Fluorouracil (3 wk) | null | N | 290025004 | CAPECITABINE |
| 290005625 | 290004074 | 1.75 | 102 | Palliative (P) | 2014-10-26 | 2014-11-03 | Trial Unspecified | N | N | 290025047 | CETUXIMAB + RT |
| 290005626 | 290004074 | 1.78 | null | Curative (C) | 2018-12-09 | 2018-12-20 | Gemcitabine weekly | N | N | 290025047 | CARBOPLATIN |
| 290005627 | 290004075 | null | 65 | Palliative (P) | 2015-12-06 | 2015-12-06 | OCTREOTIDE | 2 | N | 290025181 | GEMCITABINE |
| 290005628 | 290004076 | 1.66 | null | Palliative (P) | 2013-07-18 | 2013-07-31 | Azacitidine | N | N | 290025204 | TRIAL |
| 290005629 | 290004077 | 1.71 | 107.2 | null | 2018-05-31 | 2018-05-31 | Trial Unspecified | 02 | null | 290025217 | OCTREOTIDE |
| 290005630 | 290004078 | 0 | 75.2 | Palliative (P) | 2017-09-20 | 2017-10-05 | CISPLATIN + FLUOROURACIL | N | N | 290025219 | CAPECITABINE + RT |
| 290005631 | 290004079 | 1.7 | 48.05 | Curative (C) | 2018-12-07 | 2018-12-07 | LANREOTIDE | 02 | null | 290025259 | PLATO TRIAL |
| 290005632 | 290004080 | 1.58 | 55 | Palliative (P) | 2018-05-29 | 2018-05-29 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 290025291 | KESTREL TRIAL |
| 290005633 | 290004080 | 1.87 | null | Curative (C) | 2014-06-22 | 2014-07-20 | Cisplatin + Docetaxel +Fluorouracil | 02 | Y | 290025291 | TRIAL |
| 290005634 | 290004081 | 1.77 | 54.15 | null | null | 2016-09-26 | LANREOTIDE | null | null | 290025330 | CAPECITABINE + CARBOPLATIN |
| 290005635 | 290004082 | 1.52 | 73 | Curative (C) | 2017-04-30 | 2018-06-29 | VDC | 2 | N | 290025374 | CARBOPLATIN + PACLITAXEL |
| 290005636 | 290004082 | null | 87.1 | Curative (C) | 2016-10-31 | 2016-10-31 | Capecitabine + Cisplatin + RT | N | Y | 290025374 | SUNITINIB |
| 290005637 | 290004083 | 1.65 | 88 | Curative (C) | 2016-01-17 | 2016-01-17 | Capecitabine | 01 | N | 290025403 | CAPECITABINE + CISPLATIN + RT |
| 290005638 | 290004083 | 1.7 | 73.8 | Disease modification (D) | 2016-06-15 | 2016-06-15 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 290025403 | CAPECITABINE + RT |
| 290005639 | 290004083 | 1.8 | 82.5 | Neo-adjuvant (N) | 2016-02-02 | 2016-02-08 | LANREOTIDE | N | N | 290025403 | CETUXIMAB |
| 290005640 | 290004084 | 1.87 | 60.8 | null | 2017-04-13 | 2017-04-25 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 290025461 | CISPLATIN + FLUOROURACIL |
| 290005641 | 290004084 | 1.48 | 71.2 | Adjuvant (A) | 2014-03-04 | 2015-02-14 | Cisplatin +Fluorouracil (2 wk) | N | N | 290025461 | CAPECITABINE + RT |
| 290005642 | 290004085 | null | 98 | null | null | 2016-07-08 | Hydroxycarbamide | N | N | 290025517 | CISPLATIN + FLUOROURACIL + RT |
| 290005643 | 290004085 | null | 54.45 | Palliative (P) | 2015-10-06 | 2017-07-17 | CVP R | N | N | 290025517 | IRINOTECAN + MDG |
| 290005644 | 290004085 | 1.48 | null | Palliative (P) | 2017-08-20 | 2017-08-23 | Cisplatin + Etoposide + RT | N | N | 290025517 | CAPECITABINE + CARBOPLATIN |
| 290005645 | 290004085 | 1.6 | 59.8 | Neo-adjuvant (N) | 2015-02-26 | 2015-03-24 | CAPECITABINE + CISPLATIN + EPIRUBICIN | N | Y | 290025517 | FLUOROURACIL |
| 290005646 | 290004085 | 1.63 | 46.3 | Curative (C) | 2017-12-18 | 2018-01-15 | Cisplatin + Etoposide po&iv 3 day | N | Y | 290025517 | CAPECITABINE |
| 290005647 | 290004086 | null | 98 | Palliative (P) | 2016-09-25 | 2016-10-06 | CARBOPLATIN + RT | N | N | 290025560 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005648 | 290004087 | 1.77 | 90.4 | Not known (9) | null | 2013-12-03 | Trial Unspecified | N | Y | 290025570 | IPILIMUMAB |
| 290005649 | 290004088 | 1.64 | 64.5 | Curative (C) | 2016-04-02 | 2016-04-16 | CHOP R - 21 days | 01 | Y | 290025572 | LANREOTIDE |
| 290005650 | 290004089 | null | 65 | Palliative (P) | 2017-09-11 | 2017-09-14 | Carboplatin AUC 2 - 5 | Y | N | 290025621 | BENDAMUSTINE + RITUXIMAB |
| 290005651 | 290004089 | 1.53 | null | Curative (C) | 2016-02-05 | 2016-02-25 | Capecitabine 5days + RT | 2 | N | 290025621 | CAPECITABINE + RT |
| 290005652 | 290004090 | 1.66 | 54.4 | Disease modification (D) | 2014-10-24 | 2014-10-24 | CAPECITABINE + RT | 2 | N | 290025707 | CAPECITABINE + CISPLATIN |
| 290005653 | 290004090 | 1.65 | 101.7 | Disease modification (D) | 2017-12-24 | 2018-01-04 | ECX | N | N | 290025707 | METHOTREXATE HIGH DOSE |
| 290005654 | 290004091 | 1.58 | 72.7 | null | 2017-12-12 | 2017-12-12 | CARBOPLATIN + RT | 02 | N | 290025890 | CAPECITABINE + STREPTOZOCIN |
| 290005655 | 290004092 | 1.59 | 53.9 | Palliative (P) | null | 2013-09-14 | IDARUBICIN | null | N | 290025908 | ECX |
| 290005656 | 290006728 | 1.66 | 81.9 | Neo-adjuvant (N) | 2018-01-20 | 2018-02-04 | Cetuximab + Radiotherapy Load | 02 | N | 290026006 | LANREOTIDE |
| 290005657 | 290004093 | 1.64 | 56.3 | null | 2015-08-17 | 2015-08-19 | CAPECITABINE + RT | 02 | null | 290026071 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005658 | 290006729 | 1.5 | 70.2 | Disease modification (D) | 2015-11-05 | 2015-11-09 | Trial Unspecified | N | N | 290026080 | CARBOPLATIN + RT |